Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 19/20 | 0.62 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30592736 | 0.91 | IL23R (0.62) | IL23RUTS2R | |
| SCHEMBL29576242 | 0.91 | IL23R (0.59) | IL23R | |
| SCHEMBL30272483 | 0.90 | IL23R (0.63) | IL23RUTS2R | |
| SCHEMBL29461988 | 0.90 | IL23R (0.60) | IL23R | |
| SCHEMBL29868988 | 0.90 | IL23R (0.60) | IL23R | |
| SCHEMBL29754641 | 0.90 | NPY4R (0.54) | IL23R | |
| SCHEMBL30186443 | 0.89 | KISS1R (0.60) | UTS2R | |
| SCHEMBL29461972 | 0.88 | IL23R (0.63) | IL23R | |
| SCHEMBL30368198 | 0.87 | NPY1R (0.56) | IL23RUTS2R | |
| SCHEMBL30636161 | 0.86 | NPBWR1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022141500-A1 | USE OF CELL PENETRATING PEPTIDE CAPABLE OF COMBINING WITH ACTIVE SUBSTANCE AND PROMOTING EFFICACY OF ACTIVE SUBSTANCE FOR SKINCARE | 妍禾生医科技股份有限公司 | 2022-07-07 | — | — | WO | disclosed |
| EP-4023208-A1 | TOPICAL COMPOSITIONS FOR SKIN COMPRISING A CELL PENETRATING PEPTIDE AND METHODS OF USING THE SAME | ImDerma Laboratories Co., Ltd. (TW) | 2022-07-06 | — | — | EP | disclosed |
| US-20220202943-A1 | TOPICAL COMPOSITIONS FOR SKIN COMPRISING A CELL PENETRATING PEPTIDE AND METHODS OF USING THE SAME | IMDERMA LABORATORIES CO.LTD. (TW) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202943-A1 | TOPICAL COMPOSITIONS FOR SKIN COMPRISING A CELL PENETRATING PEPTIDE AND METHODS OF USING THE SAME | CUTA, NGLY1, SCNN1B | IL23R 493/4885UTS2R 2040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.